Exploring the Role of microRNAs in Glioma Progression, Prognosis, and Therapeutic Strategies
Date
2023-09-01Author
Tluli, OmarAl-Maadhadi, Mazyona
Al-Khulaifi, Aisha Abdulla
Akomolafe, Aishat F.
Al-Kuwari, Shaikha Y.
Al-Khayarin, Roudha
Maccalli, Cristina
Pedersen, Shona
...show more authors ...show less authors
Metadata
Show full item recordAbstract
Gliomas, which arise from glial cells in the brain, remain a significant challenge due to their location and resistance to traditional treatments. Despite research efforts and advancements in healthcare, the incidence of gliomas has risen dramatically over the past two decades. The dysregulation of microRNAs (miRNAs) has prompted the creation of therapeutic agents that specially target them. However, it has been reported that they are involved in complex signaling pathways that contribute to the loss of expression of tumor suppressor genes and the upregulation of the expression of oncogenes. In addition, numerous miRNAs promote the development, progression, and recurrence of gliomas by targeting crucial proteins and enzymes involved in metabolic pathways such as glycolysis and oxidative phosphorylation. However, the complex interplay among these pathways along with other obstacles hinders the ability to apply miRNA targeting in clinical practice. This highlights the importance of identifying specific miRNAs to be targeted for therapy and having a complete understanding of the diverse pathways they are involved in. Therefore, the aim of this review is to provide an overview of the role of miRNAs in the progression and prognosis of gliomas, emphasizing the different pathways involved and identifying potential therapeutic targets.
Collections
- Medicine Research [1382 items ]